当前位置: 首页 > 期刊 > 《健康必读(上旬刊)》 > 20203
编号:13502099
富马酸替诺福韦二吡呋酯片对慢性乙型肝炎的治疗效果(1)
http://www.100md.com 2020年3月1日 《健康必读(上旬刊)》 20203
     【摘 要】目的:探讨富马酸替诺福韦二吡呋酯片对慢性乙型肝炎的疗效。方法:随机选取30例慢性乙型肝炎患者,采用富马酸替诺福韦二吡呋酯片治疗,疗程4周;在治疗前后检测患者的肝功能和乙型肝炎病毒脱氧核糖核酸(HBV-DNA),根据这些指标的变化评价疗效。结果:与治疗前比较,治疗后丙氨酸氨基转移酶(ALT)、天冬氨酸氨基转移酶(AST)和γ-谷氨酰转肽酶(GGT)这 3种肝酶水平明显下降(P<0.05),HBV-DNA阳性率显著下降(P<0.01)。结论:富马酸替诺福韦二吡呋酯片对慢性乙型肝炎的疗效显著,不但能改善肝功能,更能有效地抑制病毒复制。

    【关键词】富马酸替诺福韦二吡呋酯片;慢性乙型肝炎;肝功能;乙型肝炎病毒

    【中图分类号】R512 【文献标识码】A 【文章编号】1672-3783(2020)03-0117-01
, 百拇医药
    Therapeutic effect of Tenofovir Dipivoxil Fumarate Tablets for Chronic Hepatitis B

    Lian Yongguang, Li Jun, Yuan Guomei, Chen Shecai

    (Xinhui Traditional Chinese Medicine Hospital,Jiangmen,Guangdong 529100 China)

    【Abstract】Objective: To probe into the therapeutic effects of tenofovir dipivoxil fumarate tablets for the chronic hepatitis B.Methods: The 30 patients of chronic hepatitis B were randomly selected and were treated to use the tenofovir dipivoxil fumarate tablets. The course of treatment was four weeks. The liver function and DNA of hepatitis B virus (HBV-DNA) for the patients were detected before and after treatment and the therapeutic effects were evaluated according to the variation of these indexes.Results:The liver enzymes levels such as the alanine aminotransferase (ALT), aspartate aminotransferase (AST) and γ-glutamyl transpeptidase (GGT) obviously reduced (P<0.05) and the positive rate of HBV-DNA apparently reduced (P<0.01) after treatment in contrast with before treatment. Conclusions: The therapeutic effects of tenofovir dipivoxil fumarate tablets for the chronic hepatitis B are apparent and this therapy not only can improve the liver function but also can effectively restrain the reproduction of virus.
, 百拇医药
    【Key words】Tenofovir dipivoxil fumarate tablets; Chronic hepatitis B; Liver function; Hepatitis B virus

    慢性乙型肝炎是由于感染乙型肝炎病毒(HBV)引起的,乙型肝炎患者和HBV攜带者是本病的主要传染源,HBV可通过母婴、血和血液制品、破损的皮肤黏膜及性接触传播。感染HBV后,由于受病毒因素、宿主因素、环境因素等影响,会出现不同的结局和临床类型。据世界卫生组织报道,全球约20亿曾感染过HBV,其中3.5亿为慢性HBV感染者,应用核苷类似物等抗病毒治疗是慢性乙型病毒肝炎的根本治疗方法[1]。本文随机选取2018年1月至2019年5月我院门诊的慢性乙型病毒肝炎患者,采用富马酸替诺福韦二吡呋酯片(简称“替诺福韦”)进行治疗,取得较好疗效,现报道如下。

    1 对象与方法

    1.1 临床病例

    随机选取门诊的慢性乙型肝炎患者30例,诊断均符合2010年中华医学会肝病分学会和感染病学会制订的《慢性乙型肝炎防治指南》[1]。排除合并其他肝炎病毒感染、自身免疫性肝病、肝硬化和肝细胞癌等肝脏疾病患者。其中男18例,女12例;年龄23~53岁(平均40.6±8.7岁)。, http://www.100md.com(梁永广 李俊 阮国梅 陈社财)
1 2下一页